Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Sep 19;10:1855-1868.
doi: 10.2147/PPA.S108678. eCollection 2016.

Professionals' Perception on the Management of Patients With Dual Disorders

Affiliations
Free PMC article

Professionals' Perception on the Management of Patients With Dual Disorders

Carlos Roncero et al. Patient Prefer Adherence. .
Free PMC article

Abstract

Background: There is a need to evaluate the professionals' perception about the consequences of the lack of therapeutic adherence in the evolution of patients with co-occurring disorders.

Methods: An online survey, released on the Socidrogalcohol [Spanish Scientific Society for Research on Alcohol, Alcoholism and other Drug Addictions] and Sociedad Española de Patología Dual [the Spanish Society of Dual Pathology] web pages, was answered by 250 professionals who work in different types of Spanish health centers where dual diagnosis patients are assisted.

Results: Most professionals perceived the existence of noncompliance among dual diagnosis patients. Almost all of these professionals (99%) perceived that noncompliance leads to a worsening of the progression of the patient's disorder, in both the exacerbation of mental disorders and the consumption of addictive substances. Most of the professionals (69.2%) considered therapeutic alliance as the main aspect to take into account to improve the prognosis in this population. The primary purpose of treatment must be the improvement of psychotic-phase positive symptoms, followed by the control of behavior disorders, reduction of craving, improvement of social and personal performances, and reduction of psychotic-phase negative symptoms.

Conclusion: Most professionals perceived low adherence among dual diagnosis patients. This lack of adherence is associated with a worsening of their disease evolution, which is reflected in exacerbations of the psychopathology and relapse in substance use. Therefore, we propose to identify strategies to improve adherence.

Keywords: decompensation; dual diagnosis; noncompliance; professionals’ perception; relapse.

Figures

Figure 1
Figure 1
Level of treatment compliance.
Figure 2
Figure 2
Common consequences of therapeutic noncompliance.
Figure 3
Figure 3
Treatment of your patients with dual pathology. Abbreviations: SSRI, selective serotonin reuptake inhibitors; NaSSA, noradrenergic and specific serotonergic antidepressant; SNRI, selective norepinephrine reuptake inhibitor; AP, antipsychotic; NDIR, noradernaline dopamine inhibitor recaptation; MAOI, monoamine oxidase inhibitor.
Figure 3
Figure 3
Treatment of your patients with dual pathology. Abbreviations: SSRI, selective serotonin reuptake inhibitors; NaSSA, noradrenergic and specific serotonergic antidepressant; SNRI, selective norepinephrine reuptake inhibitor; AP, antipsychotic; NDIR, noradernaline dopamine inhibitor recaptation; MAOI, monoamine oxidase inhibitor.

Similar articles

See all similar articles

Cited by 1 article

References

    1. Szerman N, Martinez-Raga J, Peris L, et al. Rethinking dual disorders/pathology. Addict Disord Their Treat. 2013;12:1–10.
    1. Szerman N, Martinez-Raga J. Two different mental disorders? Advancing in dual diagnosis. Dual Disord. 2015;8:2.
    1. Volkow ND. Addiction and co-occurring mental disorders. Director’s perspective. Natl Inst Drug Abuse NIDA Notes. 2007;21:2.
    1. World Health Organization [webpage on the Internet] Lexicon of Alcohol and Drug Terms. Geneva: 1994. [Accessed February 22, 2015]. Available from: http://whqlib-doc.who.int/publications/9241544686.pdf?ua=1.
    1. McGovern MP, Lambert-Harris C, Gotham HJ, Claus RE, Xie H. Dual diagnosis capability in mental health and addiction treatment services: an assessment of programs across multiple state systems. Adm Policy Ment Health. 2014;41(2):205–214. - PMC - PubMed

LinkOut - more resources

Feedback